Compound ID | 609

Update compound information

HMR 1043

Class: Lipopeptide

Spectrum of activity: Gram-negative
Details of activity: Antistaphylococcal
Institute where first reported: Aventis (Sanofi-Aventis, France)
Year first mentioned: 2000
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: Antibiotic research closed down by Aventis in 2002
External links:
Citations:
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC182620/
  • https://journals.asm.org/doi/10.1128/aac.47.9.3025-3029.2003

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.